1% Tirbanibulin Ointment Proves Effective for Actinic Keratosis Lesions
Pooled data analyses on efficacy, safety, and 1-year follow-up on the use of tirbanibulin for the treatment of actinic keratosis lesions was presented at the AAD VMX 2021.
Pooled data analyses on efficacy, safety, and 1-year follow-up on the use of tirbanibulin for the treatment of actinic keratosis lesions was presented at the AAD VMX 2021.
The short-term and long-term safety and benefit-risk profiles of drugs used to treat moderate to severe psoriasis were compared.
The researchers’ objective was to determine whether machine learning-derived estimated individual corticosteroid therapy effect yields better results than treat all or treat no one strategies in adult patients with septic shock.
Further research on blood perfusion in the keloid boundary is needed as well as on laser-assisted steroid treatments, authors of this letter believe.
To develop microbiome drugs, scientists will need to address challenges in safety, uniformity, and delivery.
Cumulative exposure to potent and very potent topical corticosteroids’ association with the risk for osteoporosis and major osteoporotic fracture was examined.
The benefit of a combination of dupilumab treatment with a short course of narrow-band ultraviolet B phototherapy for patients with severe atopic dermatitis was quantified.
The effectiveness and safety of systemic immunomodulatory treatments for patients with atopic dermatitis are compared in a systematic review and network meta-analysis.
Do steroids induce severe psoriasis flares at significant rates in a general psoriasis population?
The efficacy of 2 sessions of a mixture of transforming growth factor beta (TGF-β), granulocyte-monocyte colony-stimulating factor, and platelet-derived growth factor to address anti-aging and promote skin rejuvenation was examined.